Biogen Exercises Option with Ionis to Develop and Commercialize Investigational ASO for SMA

NEXT STORY
Vaxart to Participate at the H.C. Wainwright BioConnect Virtual Conference
PREV STORY
Quipt Adds $13 Million in Annualized Revenue, $1.6 Million in Net Income, Anticipated $2.9 Million of Adjusted EBITDA Post Integration and 15,000 New Active Patients With Acquisition of Indiana Based Company
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Nykode Therapeutics announces first subject dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate

author_avatar
NASDAQ Market News

Tiziana Lifesciences Announces Online Publication of Two Abstracts at the American Society of Clinical Oncology (ASCO) Reporting Clinical Activity and Safety of Milciclib in Patients with Advanced Hepatocellular Carcinoma

author_avatar
NASDAQ Market News

Pluristem to Present New Data from ARS study at Radiology Conference in U.S.

HAIFA, Israel, June 29, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI), a ...

author_avatar
NASDAQ Market News